COMMUNIQUÉS West-GlobeNewswire

Avivagen Announces Distribution Agreement for Vivamune™ in Vietnam
18/10/2018
OTTAWA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has entered into a distribution agreement for Vivamune™ Health Chews in the Vietnamese market with Viphavet [...]
Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)
18/10/2018
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Press release Lund on October 18, 2018 Notice of [...]
Sales of Olainfarm Group in Nine Month Increase By 4%.
18/10/2018
Consolidated Results of September and 9 months of 2018 Preliminary consolidated Olainfarm Group sales in September 2018 reached 9.5 million euros, which represents a slight decrease of 1% compared to sales of September [...]
Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China
18/10/2018
LONDON, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in combination with [...]
Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million
18/10/2018
Press release October 18, 2018 The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million The Board of Directors of Enzymatica AB (publ) has decided to carry out a rights issue of a maximum of [...]
Rule 2.9 Announcement
18/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 October 2018 [...]
Enzymatica AB: Enzymatica signs agreement for the Japanese market
18/10/2018
Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese pharmaceutical company regarding registration, marketing, distribution and [...]
Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion
18/10/2018
Novartis to acquire Endocyte for $24 per fully diluted share in cash PSMA-617 to enhance Novartis’ industry-leading radio-ligand therapy platform WEST LAFAYETTE, Ind., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. ( [...]
Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms
18/10/2018
Novartis to acquire Endocyte to accelerate development of innovative radioligand technology for treating cancer Acquisition would add 177 Lu-PSMA-617 , a potential first-in-class radioligand therapy in Phase III [...]
Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth
18/10/2018
Net sales grew 6% (cc[1], +3% USD) mainly driven by: Cosentyx grew to USD 750 million (+37% cc) with strong volume growth across indications Entresto more than doubled to USD 271 million (+113% cc) driven by continued [...]
Novartis a enregistré, au troisième trimestre, une forte croissance et fait preuve d'une innovation dynamique, incluant des plateformes thérapeutiques avancées pour soutenir la croissance future
18/10/2018
Hausse du chiffre d'affaires net de 6% (tcc[1], +3% USD), stimulée principalement par: Cosentyx , qui a progressé à USD 750 millions (+37% tcc) grâce à une forte croissance en volume dans toutes ses indications Entresto [...]
Aclaris Announces Pricing of Public Offering of Common Stock
18/10/2018
WAYNE, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering
18/10/2018
BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of its initial public offering of 6,650,000 ordinary shares at [...]
Abattis Bioceuticals Celebrates Legalization
18/10/2018
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a [...]
PhaseBio Announces Pricing of Initial Public Offering
18/10/2018
MALVERN, Pa. and SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018
17/10/2018
CINCINNATI, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report fourth quarter and full year 2018 financial [...]
Kane Biotech Announces New Manufacturing Partner for bluestem™ Product Line
17/10/2018
Strategic Partnership Reduces Annual Overhead Costs by More than C$200,000 WINNIPEG, Manitoba, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) , today [...]
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
17/10/2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association [...]
IntelGenx Announces Proposed Equity Offering
17/10/2018
SAINT LAURENT,, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) today announced that it intends to distribute units (the “ Units ”), each Unit [...]

Pages